A drug-sensitive genetic network masks fungi from the immune system
Robert T Wheeler, Gerald R Fink, Robert T Wheeler, Gerald R Fink
Abstract
Fungal pathogens can be recognized by the immune system via their beta-glucan, a potent proinflammatory molecule that is present at high levels but is predominantly buried beneath a mannoprotein coat and invisible to the host. To investigate the nature and significance of "masking" this molecule, we characterized the mechanism of masking and consequences of unmasking for immune recognition. We found that the underlying beta-glucan in the cell wall of Candida albicans is unmasked by subinhibitory doses of the antifungal drug caspofungin, causing the exposed fungi to elicit a stronger immune response. Using a library of bakers' yeast (Saccharomyces cerevisiae) mutants, we uncovered a conserved genetic network that is required for concealing beta-glucan from the immune system and limiting the host response. Perturbation of parts of this network in the pathogen C. albicans caused unmasking of its beta-glucan, leading to increased beta-glucan receptor-dependent elicitation of key proinflammatory cytokines from primary mouse macrophages. By creating an anti-inflammatory barrier to mask beta-glucan, opportunistic fungi may promote commensal colonization and have an increased propensity for causing disease. Targeting the widely conserved gene network required for creating and maintaining this barrier may lead to novel broad-spectrum antimycotics.
Conflict of interest statement
Competing interests. The authors have declared that no competing interests exist.
Figures
References
- Underhill DM, Ozinsky A. Phagocytosis of microbes: Complexity in action. Annu Rev Immunol. 2002;20:825–852.
- Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol. 2004;42:1519–1527.
- Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18:44–69.
- Poulain D, Jouault T. Candida albicans cell wall glycans, host receptors and responses: Elements for a decisive crosstalk. Curr Opin Microbiol. 2004;7:342–349.
- Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JP. Cell wall and secreted proteins of Candida albicans: Identification, function, and expression. Microbiol Mol Biol Rev. 1998;62:130–180.
- Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, et al. A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med. 2005;202:597–606.
- Brown GD, Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol. 2005;7:471–479.
- Denning DW. Echinocandin antifungal drugs. Lancet. 2003;362:1142–1151.
- Orlean P. Biogenesis of yeast wall and surface components. In: Pringle JR, Broach JR, Jones EW, editors. The molecular and cellular biology of the yeast Saccharomyces cerevisiae. Plainview (New York): Cold Spring Harbor Laboratory Press; 1997. 1131 p.
- Meikle PJ, Bonig I, Hoogenraad NJ, Clarke AE, Stone BA. The location of (1-]3)-beta-glucans in the walls of pollen tubes of Nicotiana alata using a (1-]3)-beta-glucan-specific monoclonal-antibody. Planta. 1991;185:1–8.
- Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 2005;24:1277–1286.
- Angiolella L, Maras B, Stringaro A, Arancia G, Mondello F, et al. Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic. J Chemother. 2005;17:409–416.
- Drees BL, Sundin B, Brazeau E, Caviston JP, Chen GC, et al. A protein interaction map for cell polarity development. J Cell Biol. 2001;154:549–571.
- Pruyne D, Legesse-Miller A, Gao L, Dong Y, Bretscher A. Mechanisms of polarized growth and organelle segregation in yeast. Annu Rev Cell Dev Biol. 2004;20:559–591.
- Lesage G, Sdicu AM, Menard P, Shapiro J, Hussein S, et al. Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin. Genetics. 2004;167:35–49.
- Reinoso-Martin C, Schuller C, Schuetzer-Muehlbauer M, Kuchler K. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot Cell. 2003;2:1200–1210.
- De Bernardis F, Muhlschlegel FA, Cassone A, Fonzi WA. The pH of the host niche controls gene expression in and virulence of Candida albicans . Infect Immun. 1998;66:3317–3325.
- Fonzi WA. PHR1 and PHR2 of Candida albicans encode putative glycosidases required for proper cross-linking of beta-1,3- and beta-1,6-glucans. J Bacteriol. 1999;181:7070–7079.
- Kollar R, Reinhold BB, Petrakova E, Yeh HJ, Ashwell G, et al. Architecture of the yeast cell wall. Beta(1—>6)-glucan interconnects mannoprotein, beta(1—>)3-glucan, and chitin. J Biol Chem. 1997;272:17762–17775.
- Herrero AB, Magnelli P, Mansour MK, Levitz SM, Bussey H, et al. KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties. Eukaryot Cell. 2004;3:1423–1432.
- Zlotnik H, Fernandez MP, Bowers B, Cabib E. Saccharomyces cerevisiae mannoproteins form an external cell wall layer that determines wall porosity. J Bacteriol. 1984;159:1018–1026.
- Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol. 1999;2:363–367.
- De Nobel JG, Barnett JA. Passage of molecules through yeast cell walls: A brief essay-review. Yeast. 1991;7:313–323.
- Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4:1–23.
- Mathews HL, Witek-Janusek L. Host defense against oral, esophageal, and gastrointestinal candidiasis. In: Calderone RA, editor. Candida and candidiasis. Washington (D. C.): ASM Press; 2002. pp. 179–192.
- Tuite A, Mullick A, Gros P. Genetic analysis of innate immunity in resistance to Candida albicans . Genes Immun. 2004;5:576–587.
- Ishibashi K, Yoshida M, Nakabayashi I, Shinohara H, Miura NN, et al. Role of anti-beta-glucan antibody in host defense against fungi. FEMS Immunol Med Microbiol. 2005;44:99–109.
- Viriyakosol S, Fierer J, Brown GD, Kirkland TN. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect Immun. 2005;73:1553–1560.
- Steele C, Marrero L, Swain S, Harmsen AG, Zheng M, et al. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J Exp Med. 2003;198:1677–1688.
- Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science. 1999;285:901–906.
- Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans . Genetics. 1993;134:717–728.
- Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, et al. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med. 2003;197:1119–1124.
- Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, et al. Crystal structure of a neutralizing human IGG against HIV-1: A template for vaccine design. Science. 2001;293:1155–1159.
- Llera AS, Viedma F, Sanchez-Madrid F, Tormo J. Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69. J Biol Chem. 2001;276:7312–7319.
- Muhlschlegel FA, Fonzi WA. PHR2 of Candida albicans encodes a functional homolog of the pH-regulated gene PHR1 with an inverted pattern of pH-dependent expression. Mol Cell Biol. 1997;17:5960–5967.
- Page N, Gerard-Vincent M, Menard P, Beaulieu M, Azuma M, et al. A Saccharomyces cerevisiae genome-wide mutant screen for altered sensitivity to K1 killer toxin. Genetics. 2003;163:875–894.
- el-Sherbeini M, Clemas JA. Cloning and characterization of GNS1: A Saccharomyces cerevisiae gene involved in synthesis of 1,3-beta-glucan in vitro. J Bacteriol. 1995;177:3227–3234.
- Shahinian S, Dijkgraaf GJ, Sdicu AM, Thomas DY, Jakob CA, et al. Involvement of protein N-glycosyl chain glucosylation and processing in the biosynthesis of cell wall beta-1,6-glucan of Saccharomyces cerevisiae . Genetics. 1998;149:843–856.
- Dijkgraaf GJ, Abe M, Ohya Y, Bussey H. Mutations in Fks1p affect the cell wall content of beta-1,3- and beta-1,6-glucan in Saccharomyces cerevisiae . Yeast. 2002;19:671–690.
Source: PubMed